BackCanSino Biologics Overview

CanSino Biologics Inventory

CanSino Biologics's inventory is $410M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$405.23M
↑ 13.29% YoYΔ $47.52M vs prior year quarter

Peer trimmed avg / median

Loading

CanSino Biologics Inventory History

Loading

CanSino Biologics vs. peers: Inventory Comparison

Loading

CanSino Biologics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CanSino Biologics (CASBF) FAQ

CanSino Biologics posts a inventory of $410M as of September 2026. That compares with $360M in the prior-year period — up 13.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, CanSino Biologics's inventory was $360M. The latest reading is $410M — a 13.3% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of CanSino Biologics's financial statement story. At $410M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CASBF's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CanSino Biologics's other metric pages and overview cover the third.

Judging CanSino Biologics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in inventory easier to interpret. Start with $410M here, then scan peer and history charts to see if the gap is persistent.